"I despise men who rape children and brutalise women"

shreerupa

Shreerupa Mitra-Jha | August 22, 2014



Courtesy: Neelam Mansingh

A Padma Shri award-winning theatre director, actress and impresario, Neelam Mansingh Chowdhry is also a Sangeet Natak Akademi awardee. Her recent directorial work was License – The Untitled Saga. She has also directed Ariel Dorfman’s Nachiketa Liberetto with the Opera Circus in London. Since 1990, Mansingh Chowdhry has been teaching at the Department of Indian Theatre in Panjab University, Chandigarh.

Here’s the subject, up close and personal.

The book I am reading now: And Then, You Act: Making Art in an Unpredictable World by Anne Bogart.

My favourite theatre production: Pina  Bausch’s play Bamboo Blues

My greatest weakness: My two sons.

Person I admire the most and why: BV Karanth  and   Ebrahim Alkazi, both eminent theatre directors. Ebrahim Alkazi was the director of the National School of Drama, and I, as a student, learnt from him the intricacies of playmaking. Karanth taught me that theatre was a celebration and by nature improvisational. Both were masters in the art of play-making.

The person I despise the most and why: I hate communalist, racist and sexist people (the reasons are fairly evident). I despise countries that bomb schools, and kill children. I despise men who rape children and brutalise women, discriminate in the name of religion and caste; people who use their brute strength to terrorise the marginalised and the   disfranchised members of society.

If I was not a theatre director… I would have been a lazy, non-motivated housewife.
 
My favourite quote: “Art is not a mirror held up to reality but a hammer with which to shape it.” Bertold Brecht.

I am at present busy with… Teaching, directing and looking after my home.

I would like people to remember me as: Someone who was passionately curious and translated that quality into telling stories.

The interview appeared in the August 1 to 15, 2014 issue of the magazine.
 

Comments

 

Other News

3% of medicines are of poor quality: Survey

 More than three percent of medicines in India are ‘Not of Standard Quality’ (NSQ) and 0.0245 percent spurious, reveals a survey report on drugs quality by the ministry of health.  The survey carried out by National Institute of Biologicals (NIB), Noida found that out of the

BEL unveils new weapon system for MBT Arjun tank

 Bharat electronics limited (BEL) has launched a new weapon control system — Remote Controlled Weapon Station (RCWS) / Air Defence Weapon Station (ADWS) for 12.7 mm gun of MBT Arjun Mk II battle tank during recently concluded Aero India 2017 in Bengaluru. The new weapon control system

Sasikala camp in talks with OPS faction

 The Sasikala camp is in talks with the O Panneerselvam (OPS) faction and they are trying to win them over, says an AIADMK insider. Negotiation have started between the main AIADMK, which is with Sasikala, and the splinter group that is supporting former chief minister OPS. The party insider

Stories to read over the weekend

On October 1 last year, Mehtab Alam Ansari, 30, who worked as a tailor in Delhi, had arrived in his village, Chepa Khurd in Barkagaon tehsil of Harazibagh district, to celebrate Eid with his family. That morning, he was nearing Dadi Kalan, a neighbouring village, to meet an acquaintance when he hea

ONGC to invest of Rs 7,327 cr for five projects

  State run enterprise oil and natural gas corporation limited (ONGC) has decided to invest Rs 7,327 crore to develop five projects to produce oil and gas. The decision was taken in its 290th board meeting held on February 23. The projects include development of R-Series fields, incl

Shiv Sena may again ally with BJP

The civic election results could well have long term implications in Maharashtra’s politics, with the Bharatiya Janata Party (BJP) doing dramatically well and the Shiv Sena failing to get a simple majority.   The Shiv Sena won 84 seats, while the BJP bagged 82 seats. Th

Video

Digital Transformation Summit

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter